Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 5 | 2020 | 70 | 1.660 |
Why?
|
| Internship and Residency | 5 | 2020 | 146 | 1.510 |
Why?
|
| Rheumatic Fever | 4 | 2016 | 10 | 0.990 |
Why?
|
| Streptococcal Infections | 3 | 2020 | 37 | 0.750 |
Why?
|
| Physicians | 3 | 2020 | 188 | 0.650 |
Why?
|
| Glomerulonephritis | 1 | 2020 | 13 | 0.650 |
Why?
|
| Schools, Medical | 3 | 2020 | 208 | 0.590 |
Why?
|
| Cardiac Myosins | 2 | 2016 | 7 | 0.590 |
Why?
|
| Professional Practice Location | 2 | 2020 | 17 | 0.580 |
Why?
|
| Length of Stay | 1 | 2020 | 229 | 0.580 |
Why?
|
| Hawaii | 11 | 2024 | 2011 | 0.570 |
Why?
|
| Thoracic Wall | 1 | 2017 | 1 | 0.550 |
Why?
|
| Joint Instability | 1 | 2017 | 5 | 0.550 |
Why?
|
| Chest Pain | 1 | 2017 | 49 | 0.530 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 48 | 0.520 |
Why?
|
| Streptococcus pyogenes | 5 | 2020 | 29 | 0.510 |
Why?
|
| Sex Factors | 1 | 2020 | 1028 | 0.500 |
Why?
|
| Autoantibodies | 1 | 2016 | 117 | 0.460 |
Why?
|
| Suction | 1 | 2014 | 5 | 0.430 |
Why?
|
| Ganglion Cysts | 1 | 2014 | 3 | 0.430 |
Why?
|
| Methotrexate | 1 | 2014 | 22 | 0.430 |
Why?
|
| Knee Joint | 1 | 2014 | 12 | 0.430 |
Why?
|
| Education, Medical | 1 | 2015 | 118 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 203 | 0.390 |
Why?
|
| Child, Preschool | 6 | 2024 | 1546 | 0.260 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2007 | 14 | 0.260 |
Why?
|
| Rheumatology | 1 | 2007 | 19 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2012 | 502 | 0.260 |
Why?
|
| Referral and Consultation | 1 | 2007 | 142 | 0.240 |
Why?
|
| Humans | 18 | 2024 | 43102 | 0.230 |
Why?
|
| Child | 7 | 2020 | 3443 | 0.220 |
Why?
|
| History, 21st Century | 2 | 2015 | 83 | 0.210 |
Why?
|
| History, 20th Century | 2 | 2015 | 121 | 0.210 |
Why?
|
| Odds Ratio | 2 | 2020 | 587 | 0.200 |
Why?
|
| Poverty | 1 | 2006 | 400 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 734 | 0.180 |
Why?
|
| Adolescent | 6 | 2017 | 6081 | 0.180 |
Why?
|
| Treatment Outcome | 2 | 2017 | 1604 | 0.180 |
Why?
|
| Female | 8 | 2020 | 24698 | 0.170 |
Why?
|
| Cultural Diversity | 1 | 2002 | 193 | 0.160 |
Why?
|
| Empathy | 1 | 2019 | 33 | 0.150 |
Why?
|
| Burnout, Professional | 1 | 2019 | 31 | 0.150 |
Why?
|
| Clergy | 1 | 2019 | 13 | 0.150 |
Why?
|
| Japan | 2 | 2015 | 348 | 0.150 |
Why?
|
| Terminal Care | 1 | 2019 | 54 | 0.140 |
Why?
|
| Incidence | 2 | 2020 | 1078 | 0.140 |
Why?
|
| Epitopes | 2 | 2016 | 157 | 0.140 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 106 | 0.140 |
Why?
|
| Male | 8 | 2024 | 23409 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2017 | 183 | 0.130 |
Why?
|
| Faculty | 2 | 2019 | 105 | 0.120 |
Why?
|
| Health Personnel | 1 | 2019 | 277 | 0.120 |
Why?
|
| Hospitalization | 1 | 2020 | 485 | 0.120 |
Why?
|
| Acute Disease | 3 | 2007 | 155 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2015 | 5 | 0.110 |
Why?
|
| History, 18th Century | 1 | 2015 | 6 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 719 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1067 | 0.110 |
Why?
|
| Arthralgia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Range of Motion, Articular | 1 | 2014 | 37 | 0.100 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 37 | 0.100 |
Why?
|
| Career Choice | 1 | 2013 | 52 | 0.100 |
Why?
|
| Publications | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2016 | 1759 | 0.090 |
Why?
|
| Adult | 4 | 2020 | 13872 | 0.090 |
Why?
|
| Rheumatic Heart Disease | 1 | 2010 | 4 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 587 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 269 | 0.080 |
Why?
|
| Virulence Factors | 1 | 2010 | 125 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 200 | 0.070 |
Why?
|
| Penicillins | 1 | 2007 | 10 | 0.070 |
Why?
|
| Hospitals, Rural | 1 | 2007 | 25 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 42 | 0.060 |
Why?
|
| Urban Health | 1 | 2007 | 101 | 0.060 |
Why?
|
| Chorea | 1 | 2006 | 2 | 0.060 |
Why?
|
| Antibodies | 1 | 2006 | 144 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 595 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2024 | 17 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2024 | 48 | 0.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 11 | 0.050 |
Why?
|
| Prevalence | 2 | 2007 | 1612 | 0.050 |
Why?
|
| Rural Population | 1 | 2007 | 373 | 0.050 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 25 | 0.050 |
Why?
|
| Infant | 1 | 2007 | 1175 | 0.050 |
Why?
|
| Philippines | 1 | 2002 | 81 | 0.040 |
Why?
|
| China | 1 | 2002 | 229 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 281 | 0.040 |
Why?
|
| Health Resources | 1 | 2019 | 37 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2003 | 2544 | 0.040 |
Why?
|
| Curriculum | 1 | 2019 | 318 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2006 | 2157 | 0.030 |
Why?
|
| Depression | 2 | 2019 | 863 | 0.030 |
Why?
|
| Anxiety | 2 | 2019 | 874 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2010 | 32 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 56 | 0.020 |
Why?
|
| Pharynx | 1 | 2010 | 16 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 37 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 39 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 206 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 259 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 171 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 515 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 983 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 780 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1542 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 704 | 0.020 |
Why?
|
| G(M2) Ganglioside | 1 | 2006 | 4 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2006 | 8 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2006 | 16 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2003 | 63 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 432 | 0.010 |
Why?
|
| Aggression | 1 | 2003 | 102 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 760 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 1009 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1234 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 497 | 0.010 |
Why?
|
| United States | 1 | 2007 | 5205 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 830 | 0.010 |
Why?
|
| Risk Factors | 1 | 2003 | 3994 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 16992 | 0.000 |
Why?
|